The superoxide dismutases (SODs) defend the cell against superoxide accumulation.  The Germain Lab now has an interesting paper showing that in breast cancer the there is a switch from predominant SOD2 to predominant SOD1 expression.  If you then inhibit SOD1 using the small molecule LCS-1 developed in the Varmus lab you can kill these cells effectively.